Zoetis Inc, founded in 2013 and headquartered in Parsippany, New Jersey, is a global leader in animal health, dedicated to providing solutions that enhance the health and productivity of livestock and companion animals. The company offers a comprehensive portfolio of products, including vaccines, anti-infectives, diagnostic tools, and more, aimed at improving animal health and welfare.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| ZTS 0.00% 2047-09-12 USDZoetis Inc | United States | 2047-09-12 | 0.000 | 5.32 |
| ZTS 2.00% 2030-05-15 USDZoetis Inc | United States | 2030-05-15 | 2.000 | 4.04 |
| ZTS 3.00% 2027-09-12 USDZoetis Inc | United States | 2027-09-12 | 3.000 | 3.74 |
| ZTS 3.00% 2050-05-15 USDZoetis Inc | United States | 2050-05-15 | 3.000 | 5.40 |
| ZTS 3.90% 2028-08-20 USDZoetis Inc | United States | 2028-08-20 | 3.900 | 3.84 |
| ZTS 4.15% 2028-08-17 USDZoetis Inc | United States | 2028-08-17 | 4.150 | 3.81 |
| ZTS 4.45% 2048-08-20 USDZoetis Inc | United States | 2048-08-20 | 4.450 | 5.43 |
| ZTS 4.50% 2025-11-13 USDZoetis Inc | United States | 2025-11-13 | 4.500 | 3.30 |
| ZTS 4.70% - USDZoetis Inc | United States | — | 4.700 | 5.54 |
| ZTS 4.70% 2043-02-01 USDZoetis Inc | United States | 2043-02-01 | 4.700 | 5.36 |
| ZTS 5.00% 2035-08-17 USDZoetis Inc | United States | 2035-08-17 | 5.000 | 4.71 |
| ZTS 5.40% 2025-11-14 USDZoetis Inc | United States | 2025-11-14 | 5.400 | 3.70 |
| ZTS 5.60% 2032-11-16 USDZoetis Inc | United States | 2032-11-16 | 5.600 | 4.34 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Zoetis has a strong presence in the bond market, having issued its first bonds shortly after its spin-off from Pfizer in 2013. Notably, the company issued $1.5 billion in bonds in 2020 to finance acquisitions and strengthen its balance sheet, with current yields competitive within the animal health industry. Recent bonds include features such as callable options, allowing for greater financial flexibility. Amid ongoing growth and expansion, Zoetis has maintained a stable credit rating, reflecting solid demand for its products and robust cash flow generation.